The Valley Desk

NCT00074308 · Interventional trial

Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers

Overall registry status Completed

Phase 1 · Phase 2

Conditions Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma, Unspecified Adult Solid Tumor, Protocol Specific

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov